Selected Publications and Presentations
What Brands to NEED to know to Successfully Protect Exclusivity in the Regulatory Framework
|
November 23-25, 2010
Speaker, Canadian Institute Conference, Montreal
Pharma Patents - How to Successfully Protect Exclusivity in the Patent/Regulatory Framework
Speaker, Canadian Institute Conference, Toronto
|
November 4-5, 2010
Drafting Complex Licensing Agreements
Speaker, Federated Press Conference: Mastering IP & IT Transactions, Toronto
|
October 12-13, 2010
Intellectual Property
Speaker, Innovation & Commercialization Conference
|
June 10, 2010
Biotech Licensing and Alliances
Global Business and Legal Seminars, CLE seminar webcast
|
June 2010
Essentials of Commercial Contracts
Speaker, Federated Press Conference
|
May 27-28, 2010
Canada's Approach to Functional Foods
Update magazine, Issue 2
|
March/April 2010
With permission from FDLI
Architects of Alliances 2010: Fundamentals of North American Licensing
Course co-leader, Montreal
|
April 20-21, 2010
Strategic Alliances - The Pharma Perspective
Panel Moderator, BioFinance 2010, Toronto
|
April 7, 2010
Outsourcing Creation and Innovation Discussion Forum
Speaker, 5th Annual Global Sourcing Forum, Rotman Institute for International Business and Centre for Outsourcing Research and Education (CORE), Toronto
|
March 3, 2010
View video
Introduction to Drug Law and Regulation: A Program on Understanding How the Government Regulates the Drug Industry
Speaker, The Food and Drug Law Institute, Washington, DC
|
February 17-18, 2010
Comparing Options in Commercialization Strategy: Critical Advice and Exchange of Best Practices
Speaker, Canadian Institute, Toronto
|
December 1-2, 2009
CIPO's New Draft Guidelines Could Result in Higher Disclosure Standards for Canadian Patents
Intellectual Property Bulletin
|
November 25, 2009
IP Due Diligence
Speaker, CCCA Effective Due Diligence seminar, Toronto
|
November 10, 2009
Drafting Complex Licensing Agreements
Speaker, Federated Press, Toronto
|
October 26-27, 2009
Canada Proposes Amendments to Adverse Drug Reaction Reporting
Reproduced with permission of the publisher from Health Law in Canada, vol. 30, no. 1
|
October 2009
Biosimilars in Canada: New Draft Guidelines from Health Canada
Update magazine, Issue 4
|
July/August 2009
With permission from FDLI
Cited in Canadian Pharmacists Journal
1st Annual "Tomorrow Now" High School & 3rd Annual Visions Science Fair
Judge, Visions of Science Network for Learning in partnership with Torys LLP, Toronto
|
May 2, 2009
Issues and Challenges in Building Successful Biologics
Panelist, BioFinance 2009, Toronto
|
April 28-30, 2009
U.S. Medical Device Companies—Laws and Regulations to Watch for When Selling Medical Devices in Canada
Speaker, MedTech Trade Association Meeting, Upstate New York
|
April 8, 2009
Strategic IP Portfolio Management
Moderator and speaker, Canadian Corporate Counsel Association 2009 National Spring Conference, Montreal
|
April 5-7, 2009
Data Protection for "Innovative Drugs" – Guidance Now Final
Torys Food and Drug Regulatory Bulletin
|
April 2, 2009
Republished in Health Law in Canada, vol. 29, no. 3, May 2009
Understanding Patents
Lecturer, University of Waterloo, School of Pharmacy (Health Sciences)
|
March 9, 2009
Promotion of Drugs and Devices at International Conferences Held in Canada
Update magazine, Issue 1
|
January/February 2009
With permission from FDLI. Reprinted in Health Law in Canada, vol. 30, no. 1, October 2009.
Related podcast
International Pharmaceutical Academy conference on Biosimilars
Speaker, Toronto, Ontario
|
December 4-5, 2008
4th Annual Biosimilars Conference 2008
Speaker, Philadelphia, Pennsylvania
|
November 11-13, 2008
Direct to Physician—Addressing Legal and Compliance Issues in Direct to Physician Advertising, Grants and Sponsorships to Improve Adherence Rates
Speaker, The Strategy Institute's 4th Annual Patient Adherence Conference, Toronto
|
November 6-7, 2008
The Canadian Institute's 7th Annual Forum on Pharma Patents
Co-chair, Toronto
|
October 30-31, 2008
Biologics and Subsequent Entry Biologics: Patent Protection and Regulation
Speaker, The Canadian Institute's 7th Annual Forum on Pharma Patents, Toronto
|
October 30, 2008
GMPs—A Legal Perspective
Speaker, International Pharmaceutical Academy's GMP Update 2008, Toronto
|
October 20-21, 2008
Sanofi Pasteur Healthcare & Biotechnology Venture Challenge
Judge, Toronto
|
2008
Issues and Opportunities in Due Diligence Reviews, a Business Development Course
Speaker, Architects of Alliances, Toronto
|
September 10-11, 2008
Exclusive Protection of Pesticide Data at Risk in Canada
Intellectual Property Bulletin
|
June 12, 2008
Proposed Amendments to the Patented Medicines
Co-author, Informa Law's Pharmaceutical Law Insight, vol. 4, no. 6, London
|
June 2008
Follow-on Biologics in Canada: A Look at the New Draft Guidelines
This article originally appeared in Update, issue 3. Reprinted with permission of the Food and Drug Law Institute (FDLI) ©2008
|
May/June 2008
Biotech Patents—What's Happened Recently—What's on the Horizon?
Panel chair, BioFinance, Toronto
|
May 8, 2008
CryoCath and Croycor: An Overview of Patent Litigation and the Implications
Co-leader, Blackmont Capital Seminar, Toronto
|
April 23, 2008
Life Cycle Management of Drugs—A Patent/Regulatory/Legal Perspective
Rotman School of Management (University of Toronto), Toronto
|
March 11, 2008
The Pharma/Biotech Legal Landscape
Panelist, Torys' Seminar, Montréal
|
March 4, 2008